ClinicalTrials.gov
public full text
Public Domain
A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers
The purpose of this study is to assess the effect of renal impairment on the pharmacokinetics (PK) of pasireotide,the PK of pasireotide in subjects with different degrees of renal impairment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- EVP-6124 Renal Impairment Study#1010175
- Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.#812088
- The PK/PD Study of SHR7280 Tablets in Healthy Subjects.#1047704
- To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects#877199
- A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337#892109
Record · ID 1152529
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive